DD219212A5 - Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors - Google Patents

Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors Download PDF

Info

Publication number
DD219212A5
DD219212A5 DD83254447A DD25444783A DD219212A5 DD 219212 A5 DD219212 A5 DD 219212A5 DD 83254447 A DD83254447 A DD 83254447A DD 25444783 A DD25444783 A DD 25444783A DD 219212 A5 DD219212 A5 DD 219212A5
Authority
DD
German Democratic Republic
Prior art keywords
plasmid
dna
gene
restriction
fragment
Prior art date
Application number
DD83254447A
Other languages
German (de)
English (en)
Inventor
Charles L Hershberger
Paul R Rosteck Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD219212A5 publication Critical patent/DD219212A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DD83254447A 1982-09-03 1983-09-01 Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors DD219212A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/414,290 US4530904A (en) 1982-09-03 1982-09-03 Method for conferring bacteriophage resistance to bacteria

Publications (1)

Publication Number Publication Date
DD219212A5 true DD219212A5 (de) 1985-02-27

Family

ID=23640821

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83254447A DD219212A5 (de) 1982-09-03 1983-09-01 Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors

Country Status (20)

Country Link
US (1) US4530904A (fr)
EP (1) EP0105608A1 (fr)
JP (1) JPS5978692A (fr)
KR (1) KR840005843A (fr)
AU (1) AU560689B2 (fr)
CA (1) CA1214126A (fr)
DD (1) DD219212A5 (fr)
DK (1) DK396283A (fr)
ES (1) ES8507001A1 (fr)
FI (1) FI86993C (fr)
GB (1) GB2126237B (fr)
GR (1) GR78978B (fr)
HU (1) HU202585B (fr)
IE (1) IE55672B1 (fr)
IL (1) IL69591A (fr)
NZ (1) NZ205418A (fr)
PH (1) PH19681A (fr)
PL (1) PL243620A1 (fr)
PT (1) PT77270B (fr)
ZA (1) ZA836394B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732859A (en) * 1982-09-03 1988-03-22 Eli Lilly And Company Method for conferring bacteriophage resistance to bacteria
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4774182A (en) * 1984-06-29 1988-09-27 Wisconsin Alumni Research Foundation Partially defective foreign gene for conferring immunity on a biological host
US5200333A (en) * 1985-03-01 1993-04-06 New England Biolabs, Inc. Cloning restriction and modification genes
IN166864B (fr) * 1985-03-01 1990-07-28 New England Biolabs Inc
US5180673A (en) * 1985-03-01 1993-01-19 New England Biolabs, Inc. Cloning restriction and modification genes
US4931396A (en) * 1985-06-25 1990-06-05 North Carolina State University pTR2030, a conjugal plasmid and derivatives thereof that confer phage reisistance to group N streptococci
US5139950A (en) * 1985-06-25 1992-08-18 North Carolina State University PTR2030, a conjugal plasmid and derivatives thereof that confer phage resistance to group N streptococci
US5354680A (en) * 1986-06-06 1994-10-11 New England Biolabs, Inc. Method for producing the DdeI restriction endonuclease and methylase
DE3751923T2 (de) * 1986-06-06 1997-04-03 New England Biolabs Inc Verfahren zur Klonierung von Restriktions-Modifikationssystemen
US4883756A (en) * 1986-12-16 1989-11-28 North Carolina State University pTN1060, a conjugal plasmid and derivatives thereof that confer phage resistance to group N streptococci
EP0309145A1 (fr) * 1987-09-22 1989-03-29 Mycogen Corporation Souche de Bacillus Thuringiensis var. San Diego résistante aux bactériophages
DE58909762D1 (de) * 1988-05-20 1997-02-20 Ciba Geigy Ag Bacillus thuringiensis Transformation
US5580725A (en) * 1994-04-19 1996-12-03 North Carolina State Universtiy Method of eliminating genetic routes for bacteriophage evolution and products produced thereby
US5824523A (en) * 1994-12-30 1998-10-20 Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc. Isolated DNA encoding enzyme for phage resistance
US7247719B2 (en) * 2003-06-03 2007-07-24 Sloan-Kettering Institute For Cancer Research Primers and probes for amplification and detection of human inhibitor of DNA-binding

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
US4366246A (en) * 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
EP0001929B1 (fr) * 1977-11-08 1989-04-19 Genentech, Inc. Plasmide pour la transformation d'un hôte bactérien afin de le rendre capable d'expression polypeptidique
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
US4436815A (en) * 1981-11-27 1984-03-13 Eli Lilly And Company Method for stabilizing and selecting recombinant DNA containing host cells

Also Published As

Publication number Publication date
US4530904A (en) 1985-07-23
KR840005843A (ko) 1984-11-19
AU1861683A (en) 1984-03-08
FI86993C (fi) 1992-11-10
IE55672B1 (en) 1990-12-19
JPS5978692A (ja) 1984-05-07
FI833140A (fi) 1984-03-04
ZA836394B (en) 1985-04-24
GB2126237A (en) 1984-03-21
IL69591A (en) 1991-01-31
PT77270B (en) 1986-03-21
DK396283D0 (da) 1983-08-31
PL243620A1 (en) 1984-09-10
PT77270A (en) 1983-09-01
GB2126237B (en) 1986-02-26
PH19681A (en) 1986-06-13
GR78978B (fr) 1984-10-02
NZ205418A (en) 1986-06-11
FI86993B (fi) 1992-07-31
CA1214126A (fr) 1986-11-18
DK396283A (da) 1984-03-04
GB8323468D0 (en) 1983-10-05
ES525348A0 (es) 1985-08-16
HU202585B (en) 1991-03-28
FI833140A0 (fi) 1983-09-02
IL69591A0 (en) 1983-11-30
IE832052L (en) 1984-03-03
ES8507001A1 (es) 1985-08-16
AU560689B2 (en) 1987-04-16
EP0105608A1 (fr) 1984-04-18

Similar Documents

Publication Publication Date Title
DD216044A5 (de) Verfahren zur herstellung eines rekombinierenden dna-klonierungsvektors
DE3111405C2 (fr)
DE3177288T3 (de) Reife menschliche Leukozyten-Interferone, Verfahren zu ihrer bacteriellen Herstellung, Zwischenprodukte hierfür und Zusammensetzungen diese enthaltend.
DE3786767T3 (de) Neues Polypeptid.
DE3587558T2 (de) Rekombinante DNS-Vektoren fähig zur Apoaequorinexpression, Apoaequorinpeptide und deren Herstellung und diese Vektoren enthaltende Mikroorganismen.
DD219212A5 (de) Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors
DE2858357C2 (fr)
DE2848053A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DD209476A5 (de) Verfahren zur stabilisierung und selektierung von wirtszellen, die rekombinierende dna enthalten
DE2848052A1 (de) Synthetische dna und verfahren zu ihrer herstellung
CH663032A5 (de) Doppelstraengige dna, replizierbare plasmidische expressionstraeger zur mikrobiellen herstellung von hybrid human-leukozyten-interferon und transformierte mikroorganismen.
DE2848051A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DD203330A5 (de) Verfahren zur herstellung hybrider human-leukozyten-interferone
DE3787820T2 (de) Für Flagellin kodierende DNS und dieses enthaltender Vektor.
DE3686399T2 (de) Herstellung von thrombin-inhibitoren.
DD154022A5 (de) Verfahren zur herstellung von menschlichem pre-wachstumshormon
DD219505A5 (de) Verfahren zur herstellung von schweine-wachstumshormonaehnlichen polypeptiden
DE3588224T2 (de) Gereinigtes Interleukin-1 und für Interleukin-1 kodierende DNS und deren Herstellung, solche DNS enthaltende Vektoren und deren Herstellung und Verwendung zum Transformieren von Wirten, die die Expression von Interleukin-1 zulassen
DE3523634C2 (fr)
EP0115613B1 (fr) Séquences ADN, leur préparation, plasmides contenant ces séquences et leur utilisation pour la synthèse de produits génétiques eucaryotiques dans des procaryotes
DD208989A5 (de) Verfahren zur synthetisierung von menschlichem insulin
EP0292763A2 (fr) Préparation d'angiogénines par un procédé de technologie des gènes
DD210466A5 (de) Verfahren zur herstellung eines rekombinanten plasmids
DE68913090T2 (de) Modifizierter menschlicher PSTI.
AT394209B (de) Verfahren zur herstellung neuer mikroorganismen zur produktion von hybriden human-leukozyten-interferonen